A Glimpse Into The Expert Outlook On Health Catalyst Through 6 Analysts
A Glimpse Into The Expert Outlook On Health Catalyst Through 6 Analysts
通過6名分析師的眼光，了解對Health Catalyst的專業觀點
Analysts' ratings for Health Catalyst (NASDAQ:HCAT) over the last quarter vary from bullish to bearish, as provided by 6 analysts.
過去一個季度，6位分析師對Health Catalyst（納斯達克：HCAT）的評級從看好到看淡不一。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格總結了分析師們最近的評級，揭示了過去30天內情緒的變化並將其與前幾個月進行了比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $12.0, a high estimate of $16.00, and a low estimate of $7.00. Highlighting a 7.69% decrease, the current average has fallen from the previous average price target of $13.00.
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Investigating Analyst Ratings: An Elaborate Study
分析師評級的調查：一項詳盡的研究
A comprehensive examination of how financial experts perceive Health Catalyst is derived...
淨資產收益率（ROE）：...
登入免費觀看全文
登入/註冊